Table 4.
Effect of electroacupuncture on lower urinary symptoms and prostate specific antigen in patients with benign prostate hyperplasia.
| EG (n = 18) | CG (n = 19) | P value | |
|---|---|---|---|
| IPSS | |||
| Baseline | 22.8 ± 4.4 | 21.4 ± 3.1 | .276 |
| 3 weeks | 19.5 ± 4.3 | 18.7 ± 4.0 | .640 |
| 6 weeks | 18.0 ± 3.8 | 18.2 ± 4.5 | .932 |
| Baseline-3weeks | −3.2 ± 2.4 | −2.6 ± 3.2 | .314 |
| Baseline-6weeks | −4.4 ± 2.6 | −3.05 ± 3.8 | .175 |
| PSA (ng/mL) | |||
| Baseline | 2.5 ± 2.2 | 3.4 ± 3.5 | .589 |
| 6 weeks | 2.4 ± 2.1 | 3.4 ± 3.7 | .573 |
| Baseline-6 weeks | −0.12 ± 0.54 | −0.03 ± 1.08 | .573 |
Data present as mean ± standard deviation; EG: electroacupuncture group; CG: sham electroacupuncture group; IPSS: international prostate symptom score; PSA: prostate-specific antigen; Baseline: before electroacupuncture; 3 weeks: at finishing 3 consecutive weeks total six times electroacupuncture; 6 weeks: at finishing 6 consecutive weeks total twelve times electroacupuncture; Baseline-3 weeks: the difference between baseline and at 3 weeks; Baseline-6 weeks: the difference between baseline and at 6 weeks.